|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/51 | |
| A61K 38/10 | |||
| A61K 38/17 |
| (11) | Number of the document | 2264063 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10008795.6 |
| Date of filing the European patent application | 2006-04-28 | |
| (97) | Date of publication of the European application | 2010-12-22 |
| (45) | Date of publication and mention of the grant of the patent | 2018-06-27 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 677583 P | 2005-05-03 | US | |
| 776847 P | 2006-02-24 | US | |
| 782244 P | 2006-03-13 | US | |
| 792645 P | 2006-04-17 | US | |
| 411003 | 2006-04-25 | US |
| (72) |
Paszty, Christopher, US
Robinson, Marty Kim, GB
Graham, Kevin, US
Henry, Alistair James, GB
Hoffmann, Kelly Sue, US
Latham, John, US
Lawson, Alastair, GB
Lu, Hsieng Sen, US
Popplewell, Andy, GB
Shen, Wenyan, US
Winkler, David, US
Winters, Aaron George, US
|
| (73) |
UCB Pharma, S.A.,
Allée de La Recherche 60, 1070 Brussels,
BE
|
| (54) | SCLEROSTIN BINDING ANTIBODY |
| SCLEROSTIN BINDING ANTIBODY |